• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素释放因子类似物和片段:受体结合、活性与结构之间的相关性。

GRF analogs and fragments: correlation between receptor binding, activity and structure.

作者信息

Campbell R M, Lee Y, Rivier J, Heimer E P, Felix A M, Mowles T F

机构信息

Department of Animal Science, Hoffmann-La Roche Inc., Nutley, NJ 07110.

出版信息

Peptides. 1991 May-Jun;12(3):569-74. doi: 10.1016/0196-9781(91)90103-v.

DOI:10.1016/0196-9781(91)90103-v
PMID:1656403
Abstract

GH-releasing activity in vitro was directly correlated with GRF receptor binding affinity for all hGRF analogs examined. hGRF(1-29)-NH2 analogs with Ala15-substitution (for Gly15) displayed 4-5 times higher affinity for the GRF receptor relative to hGRF(1-44)-NH2. Replacement of Gly15 with Sar15 resulted in a dramatic loss of activity and receptor binding. The present data supports the proposal that Ala15-substitution increases receptor affinity, and hence potency, due to increased amphiphilic alpha-helical interactions. Fragments of hGRF, representative of DPP-IV and trypsin-like cleavage, are inactive as a consequence of greatly diminished GRF receptor binding. These results provide a comprehensive analysis of the structural features required for both GRF receptor binding and activation.

摘要

对于所有检测的人促生长激素释放因子(hGRF)类似物,体外促生长激素(GH)释放活性与GRF受体结合亲和力直接相关。与hGRF(1 - 44)-NH2相比,Ala15取代(取代Gly15)的hGRF(1 - 29)-NH2类似物对GRF受体的亲和力高4 - 5倍。用Sar15取代Gly15导致活性和受体结合显著丧失。目前的数据支持这样的观点,即Ala15取代由于两亲性α-螺旋相互作用增加而提高了受体亲和力,从而增强了效力。hGRF的片段,代表二肽基肽酶-IV(DPP-IV)和类胰蛋白酶裂解产物,由于GRF受体结合大大减少而无活性。这些结果对GRF受体结合和激活所需的结构特征进行了全面分析。

相似文献

1
GRF analogs and fragments: correlation between receptor binding, activity and structure.生长激素释放因子类似物和片段:受体结合、活性与结构之间的相关性。
Peptides. 1991 May-Jun;12(3):569-74. doi: 10.1016/0196-9781(91)90103-v.
2
Identification of receptor-binding pharmacophores of growth-hormone-releasing factor in rat adenopituitary.
Neuroendocrinology. 1994 Apr;59(4):363-70. doi: 10.1159/000126679.
3
Effect of lead on TRH and GRF binding in rat anterior pituitary membranes.
Toxicology. 1991;68(2):169-79. doi: 10.1016/0300-483x(91)90019-w.
4
Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.用一种肽类生长激素释放因子(GRF)拮抗剂阻断清醒大鼠垂体和下丘脑的生长激素释放因子(GRF)活性。
Endocrinology. 1989 Mar;124(3):1522-31. doi: 10.1210/endo-124-3-1522.
5
Characterization of [125I-Tyr10]human growth hormone-releasing factor (1-44) amide binding to rat pituitary: evidence for high and low affinity classes of sites.
Brain Res. 1990 Oct 1;528(2):291-9. doi: 10.1016/0006-8993(90)91670-c.
6
Pegylated peptides. V. Carboxy-terminal PEGylated analogs of growth hormone-releasing factor (GRF) display enhanced duration of biological activity in vivo.聚乙二醇化肽。五、生长激素释放因子(GRF)的羧基末端聚乙二醇化类似物在体内显示出延长的生物活性持续时间。
J Pept Res. 1997 Jun;49(6):527-37. doi: 10.1111/j.1399-3011.1997.tb01160.x.
7
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.生长激素释放因子(GRF)激活大鼠垂体前叶腺苷酸环化酶的结构要求:发现(N-乙酰基-酪氨酸1,D-精氨酸2)-GRF(1-29)-NH2作为膜上的GRF拮抗剂。
Endocrinology. 1985 Nov;117(5):1759-64. doi: 10.1210/endo-117-5-1759.
8
Synthesis and biological activity of novel C-terminal-extended and biotinylated growth hormone-releasing factor (GRF) analogs.新型C末端延伸及生物素化生长激素释放因子(GRF)类似物的合成与生物活性
Peptides. 1992 Jul-Aug;13(4):787-93. doi: 10.1016/0196-9781(92)90188-9.
9
Affinity of human growth hormone-releasing factor (1-29)NH2 analogues for GRF binding sites in rat adenopituitary.
J Med Chem. 1992 May 15;35(10):1864-9. doi: 10.1021/jm00088a023.
10
Desensitization to growth hormone-releasing factor (GRF) is associated with down-regulation of GRF-binding sites.对生长激素释放因子(GRF)的脱敏作用与GRF结合位点的下调有关。
Endocrinology. 1986 May;118(5):2045-52. doi: 10.1210/endo-118-5-2045.

引用本文的文献

1
Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.新型强效生长激素释放激素(GHRH)激动剂类似物的合成及其内分泌和心脏活性评估。
Peptides. 2014 Feb;52:104-12. doi: 10.1016/j.peptides.2013.12.010. Epub 2013 Dec 25.
2
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.人类肾细胞癌表达生长激素释放激素的不同结合位点。
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10555-60. doi: 10.1073/pnas.180313097.
3
Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone.
生长激素释放激素超活性激动剂的合成与生物学评价
Proc Natl Acad Sci U S A. 1995 May 23;92(11):4872-6. doi: 10.1073/pnas.92.11.4872.